Optimized Antiplatelet Therapy With Aspirin and Clopidogrel Improves Mortality Compared to Standard Treatment.

Trial Profile

Optimized Antiplatelet Therapy With Aspirin and Clopidogrel Improves Mortality Compared to Standard Treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Feb 2013

At a glance

  • Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Antiplatelets
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Adverse reactions
  • Acronyms BOCLA-Mort
  • Most Recent Events

    • 25 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top